Enhancing Long-Term Smoking Abstinence Among Cervical Cancer Survivors (Project ACCESS)

Launched by H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE · Dec 1, 2022

Keywords

ClinConnect Summary

The clinical trial named "Project ACCESS" is looking for ways to help women who are cervical cancer survivors or have had high-grade cervical dysplasia to quit smoking for good. The study will compare two different approaches: one involves telephone counseling that focuses on motivation and problem-solving, and the other uses personalized text messages sent to participants' smartphones. The goal is to see which method is more effective in helping these women stop smoking.

To be eligible for this trial, participants should be women aged 65 to 74 who have smoked at least 100 cigarettes in their lifetime and currently smoke at least one cigarette in the past month. They must also speak English, live in Florida, and own a working smartphone. However, those already receiving smoking cessation treatment or with a family member participating in the study cannot join. Participants can expect to receive support through either counseling or text messaging as they work toward quitting smoking, and the research team will provide guidance throughout the process.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • At least 100 cigarettes or more smoked in participants lifetime
• • Speaks English
• • Currently smoke 1 cigarette or more in the past 30 days
• • History of cervical cancer or high grade cervical dysplasia
• • Has a working smartphone
• • Has a valid home address
• • Reside in Florida at the time of study enrollment
• Exclusion Criteria:
• • Receiving behavioral or pharmacological tobacco treatment
• • Household member enrolled in this study

Trial Officials